E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer

Journal of Dermatological Science

Volumn 13, Issue 1, 1996, Pages 30-36

  Shirahama, Shigeho ^a   Furukawa, Fukumi ^a   Wakita, Hisashi ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

E cadherin; P cadherin; Skin cancer; Soluble E cadherin

Indexed keywords

CELL ADHESION MOLECULE; UVOMORULIN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SKIN CANCER;

EID: 0030271297     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00493-9     Document Type: Article

References (30)

1. [1] Takeichi M: The cadherin: cell-cell adhesion molecules controlling animal morphogenesis. Development 102: 639-655, 1988.
2. [2] Takeichi M: Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59: 237-252, 1990.
3. [3] Takeichi M: Cadherin cell adhesion receptors as a morphogenic regulator. Science 251: 1451-1455, 1991.
4. [4] Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, Abe O: Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49: 2128-2133, 1989.
5. [5] Nose A, Takeichi M: A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103: 2649-2658, 1986.
6. [6] Kadokawa Y, Fuketa I, Nose A, Takeichi M, Nakatsuji N: Expression pattern of E- and P-cadherin in mouse embryos and uteri during the peri-implantation period. Dev Growth Differ 31: 23-30, 1989.
7. [7] Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birichmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
8. [8] Frixen UH, Behrens I, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
9. [9] Shimoyama Y, Hirohashi S: Expression of E- and P-cadherin in gastric carcinoma. Cancer Res 51: 2185-2192, 1991.
10. [10] Yasui W, Sano T, Nishimura K, Kitadai Y, Ji ZQ, Yokozaki H, Ito H, Tahara E: Expression of P-cadherin in gastric carcinoma and its reduction in tumor progression. Int J Cancer 54: 49-52, 1993.
11. [11] Fujita M, Furukawa F, Fujii K, Horiguchi Y, Takeichi M, Imamura S: Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and sweat ducts. Arch Dermatol Res 284: 159-166, 1992.
12. [12] Furukawa F, Takigawa M, Matsuyoshi N, Shirahama S, Wakita H, Fujita M, Horiguchi Y, Imamura S: Cadherins in cutaneous biology. J Dermatol 21: 802-813, 1994.
13. [13] Shimoyama Y, Hirohashi S: Cadherin intercellular adhesion molecule in hepatocellular carcinoma: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 57: 131-135, 1991.
14. [14] Rasbridge SA, Giliett CE, Sampson SA, Walsh FS, Millis RR: Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169: 245-250, 1993.
15. [15] Umbas R, Schalken JA, Aalders TW, Carter BS, Karlhaus HFM, Schaafsma HE, Debruyne FMJ, Isaacs WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52: 5104-5109, 1992.
16. [16] Clark WH Jr, Bernardino EA, Mihm MC: The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 29: 705-715, 1969.
17. [17] Fredriksson T, Pettersson U: Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157: 238-244, 1978.
18. [18] Pizarro A, Benito N, Navarro P, Palacios J, Cano A, Quintanilla M, Contreras F, Oamallo C: E-cadherin expression in basal cell carcinoma. Br J Cancer 69: 157-162, 1994.
19. [19] Sakaki T, Wato M, Kaji R, Mushitnoto K, Shirasu R, Tanaka A: Correlation of E- and P-cadherin with differentiation grade and mode of invasion in gingival carcinoma. Int Pathol 44: 280-286, 1994.
20. [20] Horikoshi T, Eguchi H, Furukawa F: P-cadherin expression in malignant melanoma is associated with tumor proliferation and progression. (submitted).
21. [21] Behrens J, Mareel MM, Van Roy FM, Birchmeier W: Dissecting tumor cell invasion: epithelial cells aquire invasive properties after the loss of uvomorulin -mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
22. [22] Frixin UH, Behrens J, Sachs M, Eberele G, Voss B, Warda A, Lochner D, Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
23. [23] Horiguchi Y, Furukawa F, Fujita M, Imamura S: Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. J Histochem Cytochem 42: 1333-1340, 1994.
24. [24] Jensen PJ, Wheelock M: Regulation of urokinase plasminogen activator localization in keratinocytes by calcium and E-cadherin. Exp Cell Res 202: 190-198, 1992.
25. [25] Vassalli JD, Anppino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072, 1991.
26. [26] Gold LI, Schwimmer R, Quigley J: Human plasma fibronectin as a substrate for human urokinase. Biochem J 262: 529-534, 1989.
27. [27] Hebert CA, Baker JB: Linkage of extracellular plasminogen activator to the fibroblast cystoskeleton: co-localization of cell surface urokinase with vinculin. J Cell Biol 106: 1241-1247, 1988.
28. [28] Pollanen J, Nielsen LS, Dano K, Vaheri A: Ultrastructral localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol 106: 87-95, 1988.
29. [29] Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yamamoto M, Kato I: Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 69: 580-585, 1994.
30. [30] Matsuyoshi N, Tanaka T, Toda K, Okamoto H, Furukawa F, Imamura S: Soluble E-cadherin: a novel cutaneous disease marker. Br J Dermatol 132: 745-749, 1995.